Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Kolon TissueGene Hopes To Regain Credibility As Stock Trading Resumes
Shares Surge By Daily High
Oct 26 2022
•
By
Jung Won Shin
Korea Exchange Decides To Maintain Kolon TissueGene Listing • Source: Kolon TissueGene Inc.
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from South Korea
More from Focus On Asia